Correlation Between Biofrontera Warrants and Evaxion Biotech
Can any of the company-specific risk be diversified away by investing in both Biofrontera Warrants and Evaxion Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofrontera Warrants and Evaxion Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biofrontera Warrants and Evaxion Biotech AS, you can compare the effects of market volatilities on Biofrontera Warrants and Evaxion Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofrontera Warrants with a short position of Evaxion Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofrontera Warrants and Evaxion Biotech.
Diversification Opportunities for Biofrontera Warrants and Evaxion Biotech
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Biofrontera and Evaxion is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Biofrontera Warrants and Evaxion Biotech AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaxion Biotech AS and Biofrontera Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofrontera Warrants are associated (or correlated) with Evaxion Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaxion Biotech AS has no effect on the direction of Biofrontera Warrants i.e., Biofrontera Warrants and Evaxion Biotech go up and down completely randomly.
Pair Corralation between Biofrontera Warrants and Evaxion Biotech
Assuming the 90 days horizon Biofrontera Warrants is expected to generate 4.15 times more return on investment than Evaxion Biotech. However, Biofrontera Warrants is 4.15 times more volatile than Evaxion Biotech AS. It trades about 0.03 of its potential returns per unit of risk. Evaxion Biotech AS is currently generating about -0.28 per unit of risk. If you would invest 19.00 in Biofrontera Warrants on August 31, 2024 and sell it today you would lose (11.11) from holding Biofrontera Warrants or give up 58.47% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 90.91% |
| Values | Daily Returns |
Biofrontera Warrants vs. Evaxion Biotech AS
Performance |
| Timeline |
| Biofrontera Warrants |
| Evaxion Biotech AS |
Biofrontera Warrants and Evaxion Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biofrontera Warrants and Evaxion Biotech
The main advantage of trading using opposite Biofrontera Warrants and Evaxion Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofrontera Warrants position performs unexpectedly, Evaxion Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaxion Biotech will offset losses from the drop in Evaxion Biotech's long position.| Biofrontera Warrants vs. Bausch Health Companies | Biofrontera Warrants vs. Haleon plc | Biofrontera Warrants vs. Intracellular Th |
| Evaxion Biotech vs. Reviva Pharmaceuticals Holdings | Evaxion Biotech vs. ZyVersa Therapeutics | Evaxion Biotech vs. Unicycive Therapeutics | Evaxion Biotech vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |